WO2008057104A1 - Utilisation d'associations réversibles thermiques pour de meilleures interactions entre polymères - Google Patents

Utilisation d'associations réversibles thermiques pour de meilleures interactions entre polymères Download PDF

Info

Publication number
WO2008057104A1
WO2008057104A1 PCT/US2006/045340 US2006045340W WO2008057104A1 WO 2008057104 A1 WO2008057104 A1 WO 2008057104A1 US 2006045340 W US2006045340 W US 2006045340W WO 2008057104 A1 WO2008057104 A1 WO 2008057104A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
vinyl
meth
lens
mixtures
Prior art date
Application number
PCT/US2006/045340
Other languages
English (en)
Inventor
Jeffrey Lindhardt
Joseph C. Salamone
Daniel M. Ammon, Jr.
Roya N. Borazjani
Original Assignee
Bausch & Lomb Incorporated
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/595,385 external-priority patent/US20070123602A1/en
Application filed by Bausch & Lomb Incorporated filed Critical Bausch & Lomb Incorporated
Publication of WO2008057104A1 publication Critical patent/WO2008057104A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
    • C08L71/02—Polyalkylene oxides
    • G—PHYSICS
    • G02—OPTICS
    • G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
    • G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
    • G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
    • G02B1/041—Lenses
    • G02B1/043—Contact lenses

Definitions

  • the present invention relates generally to the development of medical devices which show thermal reversible associations with similar polymer molecules contained in the majority of device care solutions.
  • the thermal reversible association provides an enhanced interaction which leads to less bacterial adhesion and uptake on the device and sustained release of a conditioning agent.
  • Poloxamer block copolymers are known compounds and are generally available under the trademark PLURONIC. Poloxamers have the following general formula:
  • Reverse poloxamers are also known block copolymers and have the following general formula:
  • Poloxamers and reverse poloxamers have end terminal hydroxyl groups that can be functionalized.
  • An example of an end terminal functionalized poloxamer is poloxamer dimethacrylate (Pluronic F- 127 dimethacrylate) as disclosed in US Patent Publication No. 2003/0044468 to Cellesi et al.
  • U.S. Patent No. 6,517,933 discloses glycidyl-terminated copolymers of polyethylene glycol and polypropylene glycol.
  • Poloxamers and reverse poloxamers are surfactants with varying HLB values based upon the varying values of a and b, a representing the number of hydrophilic poly(ethylene oxide) units (PEO) being present in the molecule and b representing the number of hydrophobic poly(propylene oxide) units (PPO) being present in the molecule. While poloxamers and reverse poloxamers are considered to be difunctional molecules (based on the terminal hydroxyl groups) they are also available in a tetrafunctional form known as poloxamines, trade name TETRONIC. For poloxamines, the molecules are tetrafunctional block copolymers terminating in primary hydroxyl groups and linked by a central diamine. Poloxamines have the following general structure:
  • Reverse poloxamines are also known and have varying HLB values based upon the relative ratios of a to b.
  • Medical devices such as ophthalmic lenses can generally be subdivided into two major classes, namely hydrogels and non-hydrogels.
  • Non-hydrogels do not absorb appreciable amounts of water, whereas hydrogels can absorb and retain water in an equilibrium state.
  • Hydrogels are widely used as soft contact lens materials. It is known that increasing the hydrophilicity of the contact lens surface improves the wettability of the contact lenses. This in turn is associated with improved wear comfort of contact lenses. Additionally, the surface of the lens can affect the overall susceptibility of the lens to deposition of proteins and lipids from the tear fluid during lens wear. Accumulated deposits can cause eye discomfort or even inflammation. In the case of extended wear lenses (i.e. lenses used without daily removal of the lens before sleep), the surface is especially important, since extended wear lenses must be designed for high standards of comfort and biocompatibiliry over an extended period of time. Thus new devices that have the potential to yield improved surface qualities are still desirable in this field of art. BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is a graphical representation of the results of Example 3; Fig. 2 is a graphical representation of the results of Example 4. DETAILED DESCRIPTION
  • reversible thermal association refers to the properties of some polymers to undergo abrupt changes in solubility in response to increased temperature. This change in solubility favors polymer-polymer interactions rather than polymer-solvent interactions.
  • Polyethers that are present at the surface of substrates have long been known to inhibit bacterial adhesion and to reduce the amount of lipid and protein deposition (non- fouling surface).
  • the present invention relates generally to development of new prototypes of conventional hydrogel contact lenses that show improved and enhanced properties.
  • the present invention relates to a lens which shows enhanced interactions with similar polymer molecules contained in the majority of lens care solutions. The enhanced interaction leads to less bacterial adhesion and uptake and sustained release of conditioning agent.
  • Rigid gas-permeable (RGP) materials typically comprise a hydrophobic cross- linked polymer system containing less than 5 wt. % water.
  • RGP materials useful in accordance with the present invention include those materials taught in U.S. Pat. Nos.
  • the invention is applicable to a wide variety of polymeric materials, either rigid or soft.
  • polymeric materials are lenses including contact lenses, phakic and aphakic intraocular lenses and corneal implants although all polymeric materials including biomaterials are contemplated as being within the scope of this invention.
  • Hydrogels comprise hydrated, crosslinked polymeric systems containing water in an equilibrium state. Such hydrogels could be silicone hydrogels, which generally have water content greater than about five weight percent and more commonly between about ten to about eighty weight percent.
  • Such materials are usually prepared by polymerizing a mixture containing at least one siloxane-containing monomer and at least one hydrophilic monomer.
  • siloxane-containing monomeric units for use in the formation of silicone hydrogels are well known in the art and numerous examples are provided in U.S. Pat. Nos. 4,136,250; 4,153,641; 4,740,533; 5,034,461; 5,070,215; 5,260,000; 5,310,779; and 5,358,995.
  • siloxane-containing monomers having certain fluorinated side groups, i.e. — (CF 2 ) — H have been found to improve compatibility between the hydrophilic and siloxane-containing monomeric units, as described in U.S. Pat. Nos. 5,387,662 and 5,321,108.
  • the poloxamer and/or poloxamine may be functionalized to provide the desired reactivity at the end terminal of the molecule.
  • the functionality can be varied and is determined based upon the intended use of the functionalized PEO- and PPO-containing block copolymers. That is, the PEO- and PPO-containing block copolymers are reacted to provide end terminal functionality that is complementary with the intended device forming monomer mixture.
  • block copolymer we mean to define the poloxamer and/or poloxamine as having two or more blocks in their polymeric backbone(s).
  • Selection of the functional end group is determined by the functional group of the reactive molecule in the monomer mix or polymerized device. For example, if the reactive molecule contains a carboxylic acid group, glycidyl methacrylate can provide a methacrylate end group. If the reactive molecule contains hydroxy or amino functionality, isocyanato ethyl methacrylate or (meth)acryloyl chloride can provide a methacrylate end group and vinyl chloro formate can provide a vinyl end group.
  • glycidyl methacrylate can provide a methacrylate end group.
  • isocyanato ethyl methacrylate or (meth)acryloyl chloride can provide a methacrylate end group and vinyl chloro formate can provide a vinyl end group.
  • the functional group may comprise a moiety selected from amine, hydrazine, hydrazide, thiol (nucleophilic groups), carboxylic acid, carboxylic ester, including imide ester, orthoester, carbonate, isocyanate, isothiocyanate, aldehyde, ketone, thione, alkenyl, acrylate, methacrylate, acrylamide, sulfone, maleimide, disulfide, iodo, epoxy, sulfonate, thiosulfonate, silane, alkoxysilane, halosilane, and phosphoramidate.
  • amine hydrazine, hydrazide, thiol (nucleophilic groups)
  • carboxylic acid carboxylic ester, including imide ester, orthoester, carbonate, isocyanate, isothiocyanate, aldehyde, ketone, thione, alkenyl, acrylate
  • succinimidyl ester or carbonate imidazolyl ester or carbonate, benzotriazole ester or carbonate, p-nitrophenyl carbonate, vinyl sulfone, chloroethylsulfone, vinylpyridine, pyridyl disulfide, iodoacetamide, glyoxal, dione, mesylate, tosylate, and tresylate.
  • activated carboxylic acid derivatives as well as hydrates or protected derivatives of any of the above moieties (e.g.
  • Preferred electrophilic groups include succinimidyl carbonate, succinimidyl ester, maleimide, benzotriazole carbonate, glycidyl ether, imidazoyl ester, p-nitrophenyl carbonate, acrylate, tresylate, aldehyde, and orthopyridyl disulfide.
  • reaction sequences are intended to be illustrative, not limiting. Examples of reaction sequences by which PEO- and PPO-containing block copolymers can be end-functionalized are provided below:
  • PEO- and PPO-containing block copolymers are presently preferred as components capable of forming a thermal reversible association with a similar component in a solution
  • other components capable of such associations are also known.
  • E. Ruel-Gariepy and JC Leroux in Eur. J. Pharma and Biopharma 58, (2004), pp 409-426. describe a number of insitu-forming hydrogels in temperature- sensitive systems.
  • Such components capable of thermal reversible association include, for example, polysaccharides, proteins, polysaccharide derivatives, protein derivatives, N-isopropylacrylamide copolymers, poly(ethylene oxide)/(D,L-lactic acid -co-glycolic acid) copolymers and thermosensitive liposome-based systems.
  • Device Forming Additives and Comonomers include, for example, polysaccharides, proteins, polysaccharide derivatives, protein derivatives, N-isopropylacrylamide copolymers, poly(ethylene oxide)/(D,L-lactic acid -co-glycolic acid) copolymers and thermosensitive liposome-based systems.
  • the polymerizable composition may, further as necessary and within limits not to impair the purpose and effect of the present invention, contain various additives such as antioxidant, coloring agent, ultraviolet absorber and lubricant.
  • the polymerizable composition may be prepared by using, according to the end-use and the like of the resulting shaped polymer articles, one or at least two of the above comonomers and oligomers and functionalized surfactants: and, when occasions demand, one or more crosslinking agents.
  • the shaped polymer articles are for example medical products, in particular a contact lens
  • the polymerizable composition is suitably prepared from one or more of the silicon compounds, e.g. siloxanyl (meth)acrylate, siloxanyl (meth)acrylamide and silicone oligomers, to obtain contact lenses with high oxygen permeability.
  • the monomer mix of the present invention may include additional components such as crosslinking agents, internal wetting agents, hydrophilic monomeric units, toughening agents, and other components as is well known in the art.
  • compositions within the scope of the present invention may include toughening agents, preferably in quantities of less than about 80 weight percent e.g. from about 5 to about 80 weight percent, and more typically from about 20 to about 60 weight percent. Examples of suitable toughening agents are described in U.S. Pat. No. 4,327,203.
  • These agents include cycloalkyl acrylates or methacrylates, such as: methyl acrylate and methacrylate, t-butylcyclohexyl methacrylate, isopropylcyclopentyl acrylate, z'-pentylcyclo-heptyl methacrylate, t-butylcyclohexyl acrylate, isohexylcyclopentyl acrylate and methylisopentyl cyclooctyl acrylate.
  • suitable toughening agents are described in U.S. Pat. No. 4,355,147.
  • This reference describes polycyclic acrylates or methacrylates such as: isobornyl acrylate and methacrylate, dicyclopentadienyl acrylate and methacrylate, adamantyl acrylate and methacrylate, and isopinocamphyl acrylate and methacrylate. Further examples of toughening agents are provided in U.S. Pat. No. 5,270,418. This reference describes branched alkyl hydroxyl cycloalkyl acrylates, methacrylates, acrylamides and methacrylamides.
  • Representative examples include: 4-t-butyl-2-hydroxycyclohexyl methacrylate (TBE); 4-t-butyl-2-hydroxycyclopentyl methacrylate; methacryloxyamino- 4 ⁇ t-butyl-2-hydroxycyclohexane; ⁇ -isopentyl-S-hydroxycyclohexyl methaciylate; and methacryloxyamino-2-isohexyl-5-hydroxycyclopentane.
  • TBE 4-t-butyl-2-hydroxycyclohexyl methacrylate
  • TBE 4-t-butyl-2-hydroxycyclopentyl methacrylate
  • methacryloxyamino- 4 ⁇ t-butyl-2-hydroxycyclohexane ⁇ -isopentyl-S-hydroxycyclohexyl methaciylate
  • methacryloxyamino-2-isohexyl-5-hydroxycyclopentane methacryloxyamino-2-isohexyl
  • Internal wetting agents may also be used for increasing the wettability of such hydrogel compositions.
  • suitable internal wetting agents include N- alkyenoyl trialkylsilyl aminates as described in U.S. Pat. No. 4,652,622. These agents can be represented by the general formula:
  • E is hydrogen or methyl
  • G is (CH 2 ) r C(O)OSi(V) 3 or hydrogen
  • V is methyl, ethyl or propyl
  • q is an integer form 1 to 15
  • r is an integer form 1 to 10
  • q+r is an integer form 1 to 15, hereinafter referred to as NATA.
  • NAA Acryloxy- and methacryloxy-, mono- and dicarboxylic amino acids, hereinafter NAA, impart desirable surface wetting characteristics to polysiloxane polymers, but precipitate out of monomer mixtures that do not contain siloxane monomers before polymerization is completed.
  • NAA can be modified to form trialkylsilyl esters which are more readily incorporated into polysiloxane polymers.
  • the preferred NATAs are trimethylsilyl-N-methacryloxyglutamate, triethylsilyl-N-methacryloxyglutamate, trimethyl-N-methacryloxy-6-aminohexanoate, trimethylsilyl-N-methacryloxy- aminododecanoate, and bis-trimethyl-silyl-N-methacryloxyaspartate .
  • Preferred wetting agents also include acrylic and methacylic acids, and derivatives thereof. Typically, such wetting agents comprise less than 5 weight percent of the composition.
  • oxazolones as described in U.S. Pat. No. 4,810,764 to Friends et al. issued Mar. 7, 1989, the contents of which are incorporated by reference herein.
  • These preferred internal wetting agents specifically include 2-isopropenyl-4,4-dimethyl-2-oxazolin-5-one (IPDMO), 2-vinyl-4,4-dimethyl-2 ⁇ oxazolin-5-one (VDMO), cyclohexane spiro-4'-(2'isopropenyl-2'-oxazol-5'-one) (IPCO), cyclohexane-spiro-4'-(2'-vinyl-2'-oxazol-5 '-one) (VCO), and 2-(-l-propenyl)-4,4- dimethyl-oxazol-5-one (PDMO).
  • IPDMO 2-isopropenyl-4,4-dimethyl-2-oxazolin-5-one
  • These preferred internal wetting agents have two important features which make them particularly desirable wetting agents: (1) they are relatively non-polar and are compatible with the hydrophobic monomers (the polysiloxanes and the toughening agents), and (2) they are converted to highly polar amino acids on mild hydrolysis, which impart substantial wetting characteristics. When polymerized in the presence of the other components, a copolymer is formed. These internal wetting agents polymerize through the carbon-carbon double bond with the endcaps of the polysiloxane monomers, and with the toughening agents to form copolymeric materials particularly useful in biomedical devices, especially contact lenses.
  • hydrophilic monomeric units examples include those described in U.S. Pat. Nos.: 4,259,467; 4,260,725; 4,440,918; 4,910,277; 4,954,587; 4,990,582; 5,010,141; 5,079,319; 5,310,779; 5,321,108; 5,358,995; 5,387,662; all of which are incorporated herein by reference.
  • preferred hydrophilic monomers include both acrylic- and vinyl-containing monomers such as hydrophilic acrylic-, methacrylic-, itaconic-, styryl-, acrylamido-, methacrylamido- and vinyl-containing monomers
  • Preferred hydrophilic monomers may be either acrylic- or vinyl-containing. Such hydrophilic monomers may themselves be used as crosslinking agents.
  • "Acrylic-type” or "acrylic- containing" monomers are those monomers containing the acrylic group represented by the formula:
  • X is preferably hydrogen or methyl and Y is preferably ⁇ O ⁇ , --OQ--, — NH-, --NQ-- and -NH(Q)--, wherein Q is typically an alkyl or substituted alkyl group.
  • Y is preferably ⁇ O ⁇ , --OQ--, — NH-, --NQ-- and -NH(Q)--, wherein Q is typically an alkyl or substituted alkyl group.
  • Preferred hydrophilic vinyl-containing monomers which may be incorporated into the hydrogels of the present invention include monomers such as N-vinyllactams (e.g. N-vinylpyrrolidone (NVP)), N-vinyl-N-methylacetamide, N-vinyl-N- ethylacetamide, N-vinyl-N-ethylfo ⁇ namide, N-vinylformamide, with NVP being the most preferred.
  • NVP N-vinylpyrrolidone
  • DMA dimethylacrylamide
  • Suitable ethylenically unsaturated hydrophilic monomers include ethylenically unsaturated polyoxyalkylenes, polyacrylamides, polyvinylpyrrolidones, polyvinyl alcohols, poly(hydroxyethyl methacrylate) or poly (HEMA), and N-alkyl-N- vinylacetamides. Ethylenic unsaturation may be provided by (meth)acrylate, (meth)acrylamide, styrenyl, alkenyl, vinyl carbonate and vinyl carbamate groups.
  • Preferred hydrophilic macromonomers include methoxypolyoxyethylene methacrylates of molecular weights from 200 to 10,000, more preferred are methoxypolyoxyethylene methacrylates of molecular weight range of 200 to 5,000 and most preferred are methoxypolyoxyethylene methacrylates of molecular weight range of 400 to 5,000.
  • Additional preferred hydrophilic macromonomers include polyvinylpyrrolidone) methacrylates of molecular weights of 500 to 10,000. More preferred are poly(N- vinylpyrrolidone methacrylates) of molecular weights of 500 to 5,000 and most preferred are poly(N-vinylpyrrolidone) methacrylates of molecular weights of 1000 to 5,000.
  • hydrophilic macromonomers include poly(N,N-dimethyl acrylamide methacrylates) of molecular weights of 500 to 10,000. More preferred are poly(N,N- dimethylacrylamide methacrylates) of molecular weights of 500 to 5,000 and most preferred are poly(N,N-dimethylacrylamide methacrylates) of molecular weights of 1000 to 5,000.
  • Suitable ethylenically unsaturated hydrophobic monomers include alkyl (meth)acrylates, N-alkyl (meth)acrylamides, alkyl vinylcarbonates, alkyl vinylcarbamates, fluoroalkyl (meth)acrylates, N-fluoroalkyl (meth)acrylamides, N- fluoroalkyl vinylcarbonates, N-fluoroalkyl vinylcarbamates, silicone-containing (meth)acrylates, (meth)acrylamides, vinyl carbonates, vinyl carbamates, styrenic monomers [selected from the group consisting of styrene, ⁇ -methyl styrene, p-methyl styrene, p-t-butylmonochlorostyrene, and p-t-butyldichlorostyrene] and poly[oxypropylene (meth)acrylatesj.
  • Preferred hydrophobic monomers include methyl methacrylate, dodecyl methacrylate, octafluoropentyl methacrylate, hexafluoroisopropyl methacrylate, perfluorooctyl methacrylate, methacryoyloxypropyltris(trimethylsiloxy)silane (TRIS).
  • a further crosslmking agent having both a vinyl and an acrylic polymerizable group may be used, such as the crosslinkers which are the subject of U.S. Pat. No. 5,310,779, issued May 10, 1994, the entire content of which is incorporated by reference herein.
  • Such crosslinkers help to render the resulting copolymer totally UV-curable.
  • the copolymer could also be cured solely by heating, or with a combined UV and heat regimen. Photo and/or thermal initiators required to cure the copolymer will be included in the monomer mix, as is well-known to those skilled in the art.
  • compositions comprise from about 0.1 to about 50 weight percent of functionalized poloxamers and/or poloxamines, from about 0.1 to about 30 weight percent of functionalized poloxamers and/or poloxamines, and from about 0.1 to about 4.9% weight percent of functionalized poloxamers and/or poloxamines.
  • An advantage of using less than 5% of functionalized poloxamers and/or poloxamines is that the optical transmission of the device tends to decrease at higher concentrations of functionalized poloxamers and/or poloxamines.
  • the monomer mixes employed in this invention can be readily cured to desired shapes by conventional methods such as UV polymerization, or thermal polymerization, or combinations thereof, as commonly used in polymerizing ethylenically unsaturated compounds.
  • Representative free radical thermal polymerization initiators are organic peroxides, such as acetyl peroxide, lauroyl peroxide, decanoyl peroxide, stearoyl peroxide, benzoyl peroxide, t-butyl peroxypivalate, peroxydicarbonate, and the like, employed in a concentration of about 0.01 to 1 percent by weight of the total monomer mixture.
  • UV initiators are those known in the field such as, benzoin methyl ether, benzoin ethyl ether, DAROCUR 1173, 1164, 2273, 1116, 2959, 3331 (EM Industries) and IGRACUR 651 and 184 (Ciba-Geigy).
  • Polymerization of the end-functionalized poloxamers and/or poloxamines with other comonomers is generally performed (with crosslinking agents) in the presence of a diluent.
  • the polymerization product will then be in the fo ⁇ n of a gel. If the diluent is nonaqueous, the diluent may be removed from the gel and replaced with water through the use of extraction and hydration protocols well known to those of ordinary skill in the art. It is also possible to perform the polymerization in the absence of diluent to produce a xerogel. These xerogels may then be hydrated to form the hydrogels as is well known in the art.
  • the copolymer of the present invention may also include other monomers as will be apparent to one of ordinary skill in the art.
  • the monomer mix may include colorants, or UV- absorbing agents such as those known in the contact lens art.
  • the present invention provides medical devices such as heart valves and intraocular lenses, films, surgical devices, heart valves, vessel substitutes, intrauterine devices, membranes and other films, diaphragms, surgical implants, blood vessels, artificial ureters, artificial breast tissue and membranes intended to come into contact with body fluid outside of the body, e.g., membranes for kidney dialysis and heart/lung machines and the like, catheters, mouth guards, denture liners, ophthalmic devices, and especially contact lenses.
  • medical devices such as heart valves and intraocular lenses, films, surgical devices, heart valves, vessel substitutes, intrauterine devices, membranes and other films, diaphragms, surgical implants, blood vessels, artificial ureters, artificial breast tissue and membranes intended to come into contact with body fluid outside of the body, e.g., membranes for kidney dialysis and heart/lung machines and the like, catheters, mouth guards, denture liners, ophthalmic devices, and especially contact lenses.
  • the polymers of this invention can be formed into ophthalmic devices by spincasting processes (such as those disclosed in U.S. Pat. Nos. 3,408,429 and 3,496,254), cast molding, lathe cutting, or any other known method for making the devices.
  • Polymerization may be conducted either in a spinning mold, or a stationary mold corresponding to a desired shape.
  • the ophthalmic device may be further subjected to mechanical finishing, as occasion demands.
  • Polymerization may also be conducted in an appropriate mold or vessel to form buttons, plates or rods, which may then be processed (e.g., cut or polished via lathe or laser) to give an ophthalmic device having a desired shape.
  • the subject hydrogels When used in the formation of hydrogel (soft) contact lenses, it is preferred that the subject hydrogels have water contents of from about 20 to about 90 weight percent. Furthermore, it is preferred that such hydrogels have a modulus from about 20 g/mm 2 to about 150 g/mm 2 , and more preferably from about 30 g/mm 2 to about 100 g/mm 2 .
  • the device In order for the thermal reversible association between a component that comprises the medical device and a further component that comprises the solution to occur, the device is brought into contact with a solution containing like components as those that comprise the device.
  • these like components typically comprise device care solutions such as cleaning and/or storage solutions. More specifically contact lens care solutions.
  • solution components capable of forming thermal reversible association suitable for use in the present invention may also be useful as a component of a cleaning, disinfecting or conditioning solution and/or composition.
  • Such solutions and/or compositions also may include, antimicrobial agents, surfactants, toxicity adjusting agents, buffers and the like that are known to be used components of conditioning and/or cleaning solutions for contact lenses. Examples of suitable formulations for cleaning and/or disinfecting solutions are taught in U.S. Patent 5,858,937 to Richard et al., which is incorporated by reference as if set forth at length herein.
  • compositions and/or solutions of the present invention may be formulated as a "multi-purpose solution,” meaning that such compositions and/or solutions may be used for cleaning, chemical disinfection, storing, and rinsing a contact lens.
  • a multi-purpose solution preferably has a viscosity of less than 75 cps, preferably 1 to 50 cps, and most preferably 1 to 25 cps and is preferably is at least 95 percent weight by volume water in the total composition.
  • Surfactants which are suitable for use in the present invention, are classified into cationic surfactants, anionic surfactants, nonionic surfactants and ampholytic surfactants depending upon their dissociation state in their aqueous solutions.
  • various surfactants which are classified into cationic surfactants, particularly surfactants which consist of an amino acid derivative, i.e. amino acid type cationic surfactants have conventionally been proposed as disinfectant cleaning agents or compositions for disinfection.
  • Amphoteric surfactants suitable for use in a composition according to the present invention include materials of the type are offered commercially under the trade name "MIRANOL.” Another useful class of amphoteric surfactants is exemplified by cocoamidopropyl betaine, commercially available from various sources.
  • PLURONICS and reverse PLURONICS which are a series of ABA and BAB type block copolymers, respectively.
  • the ABA block copolymers are composed of poly(ethylene oxide)-poly(propylene oxide)- poly(ethylene oxide) moieties
  • the BAB block copolymers are composed of poly(propylene oxide)-poly(ethylene oxide)-poly(propylene oxide) blocks.
  • the poly(ethylene oxide), PEO, blocks are hydrophilic, whereas poly(propylene oxide), PPO, blocks are hydrophobic in nature.
  • Such materials are commercially available under the trade name PLUORONIC.
  • the poloxamers are derived from different ratios of PEO and PPO.
  • surfactants is the poloxamines, available under the trade name Tetronic, which contain blocks of PEO and PPO connected by an ethylenediamine moiety.
  • Tetronic a specific class of surfactants
  • one or more additional polymeric or non-polymeric demulcents may be combined with the above-named ingredients. Demulcents are known to provide wetting, moisturizing and/or lubricating effects, resulting in increased comfort. Polymeric demulcents can also act as a water-soluble viscosity builder.
  • water-soluble viscosity builders include the non-ionic cellulosic polymers like methyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, and carboxymethyl cellulose, polyvinylpyrrolidone), poly(vinylalcohol) and the like.
  • Such viscosity builders or demulcents may be employed in a total amount ranging from about 0.01 to about 5.0 weight percent or less.
  • the viscosity of the final formulation is 10 cps to 50 cps.
  • Comfort agents such as glycerin or propylene glycol can also be added.
  • Example 1 Synthesis of functionalized surfactants 6.00 g of PLURONIC F127 was placed in a round bottom flask and dried thoroughly via azeotropic distillation of toluene (100ml). The round bottom flask was then fitted with a reflux condenser and the reaction was blanketed with Nitrogen gas. Anhydrous tetrahydrofuran (THF) (60 ml) was added to the flask and the reaction was chilled to 5°C with 15 equivalents (based upon the hydroxy! endgroups) of triethylamine (TEA)was added (2.0 ml).
  • THF tetrahydrofuran
  • Example 3 Sustained Release of Pluronics (conditioning agent) as determined by NMR
  • NVP/TBE mix consists of 90 parts NVP and 10 parts of TBE
  • Lenses made from formulation 1 and Formulation 2 were soaked overnight in a 20% by weight Pluronic F38 solution in D 2 O. At the initiation of the experiment, lenses were removed from this soaking solution and placed on the basket of a contact lens holder. D 2 O was flushed in a controlled manner over the contact lens utilizing a syringe pump and a flow rate of 1 mL Of D 2 O per hour. The solution that was flushed over the lens was collected and proton NMR spectra were obtained to determine the concentration of Pluronic-F38. The results of this experiment are shown in Figure 1.
  • the lenses made from Formulation 2 in the table (which contains 5% by weight of Pluronic F127-dimethacrylate) released Pluronic F38 at a slower initial rate and for a longer period of time than the unmodified lenses made from Formulation 1.
  • a higher concentration of Pluronic F38 is being released from the unmodified lenses than from the modified lenses which is indicative that the Pluronic is not as tightly associated.
  • more Pluronic F38 is being released from formulation 2 than from 1 indicating that the Pluronic surfactant is released over a longer time period.
  • the crossover at around 4 hours occurs because the unmodified lens is being depleted of the Pluronic F38 due to weaker association.
  • NVP/TBE mix consists of 90 parts NVP and 10 parts of TBE Contact lenses made from the following formulations were used in microbial attachment study of lenses soaked in Pluronic F 127.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Materials For Medical Uses (AREA)
  • Eyeglasses (AREA)

Abstract

La présente invention concerne d'une manière générale le développement de dispositifs médicaux qui présentent des associations réversibles thermiques avec des molécules polymères analogues contenues dans la majorité des solutions d'entretien du dispositif. L'association réversible thermique offre une meilleure interaction qui conduit à une adhésion et une assimilation bactérienne moindres sur le dispositif et à une libération prolongée d'un agent de conditionnement.
PCT/US2006/045340 2006-11-09 2006-11-27 Utilisation d'associations réversibles thermiques pour de meilleures interactions entre polymères WO2008057104A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/595,385 US20070123602A1 (en) 2005-11-29 2006-11-09 Use of thermal reversible associations for enhanced polymer interactions
US11/595,385 2006-11-09

Publications (1)

Publication Number Publication Date
WO2008057104A1 true WO2008057104A1 (fr) 2008-05-15

Family

ID=38229806

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/045340 WO2008057104A1 (fr) 2006-11-09 2006-11-27 Utilisation d'associations réversibles thermiques pour de meilleures interactions entre polymères

Country Status (1)

Country Link
WO (1) WO2008057104A1 (fr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1517083A (en) * 1975-07-14 1978-07-12 Ceskoslovenska Akademie Ved Method of manufacturing shaped articles from crystalline acrylonitrile polymers and copolymers
EP0470703A1 (fr) * 1990-08-07 1992-02-12 MDV Technologies, Inc. Gels thermiquement réversibles et irréversibles
WO2004096309A1 (fr) * 2003-05-02 2004-11-11 Rimon Therapeutics Ltd. Implant thermiquement reversible
US20050037194A1 (en) * 2003-08-15 2005-02-17 Kimberly-Clark Worldwide, Inc. Thermoplastic polymers with thermally reversible and non-reversible linkages, and articles using same
WO2006068705A1 (fr) * 2004-12-22 2006-06-29 Bausch & Lomb Incorporated Surfactants polymerisables et leur utilisation en tant que comonomeres pour former des dispositifs

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1517083A (en) * 1975-07-14 1978-07-12 Ceskoslovenska Akademie Ved Method of manufacturing shaped articles from crystalline acrylonitrile polymers and copolymers
EP0470703A1 (fr) * 1990-08-07 1992-02-12 MDV Technologies, Inc. Gels thermiquement réversibles et irréversibles
WO2004096309A1 (fr) * 2003-05-02 2004-11-11 Rimon Therapeutics Ltd. Implant thermiquement reversible
US20050037194A1 (en) * 2003-08-15 2005-02-17 Kimberly-Clark Worldwide, Inc. Thermoplastic polymers with thermally reversible and non-reversible linkages, and articles using same
WO2006068705A1 (fr) * 2004-12-22 2006-06-29 Bausch & Lomb Incorporated Surfactants polymerisables et leur utilisation en tant que comonomeres pour former des dispositifs

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CHEN ET AL: "Temperature-induced gelation Pluronic -g-poly( acrylic acid) graft copolymers for prolonged drug delivery to the eye", 13 April 1997, ACS SYMPOSIUM SERIES, WASHINGTON, DC, US, PAGE(S) 441-457, ISSN: 0097-6156, XP002120272 *

Similar Documents

Publication Publication Date Title
US8377464B2 (en) Polymerizable surfactants and their use as device forming comonomers
JP6839295B2 (ja) 重合性ポリジメチルシロキサン−ポリオキシアルキレンブロックコポリマー
JP6859432B2 (ja) 鎖延長ポリジメチルシロキサンビニル架橋剤およびその使用
JP5473219B2 (ja) シリコーンヒドロゲルコンタクトレンズ
EP0611379B1 (fr) Compositions d'hydrogel mouillable au silicone et procedes de fabrication desdites compositions
US9529119B2 (en) Method for fabricating silicone-containing copolymer molded article having hydrophilic surface and silicone-hydrogel contact lens having hydrophilic surface
CA2394939C (fr) Lentille de contact souple pouvant etre portee longtemps
CA2860221A1 (fr) Hydrogels de silicone comprenant une teneur en eau et une permeabilite a l'oxygene souhaitables
KR20160140702A (ko) 실리콘 아크릴아미드 공중합체
US20070123602A1 (en) Use of thermal reversible associations for enhanced polymer interactions
US11061169B2 (en) Contact lens with phosphorylcholine-modified polyvinylalcohols therein
KR20160140701A (ko) 실리콘 아크릴아미드 공중합체
CN111919141A (zh) 硅氧烷水凝胶隐形眼镜
WO2007149083A1 (fr) Tensioactifs polymérisables et leur utilisation en tant que comonomères pour la formation de dispositifs
JP6857784B2 (ja) ポリマー材料
WO2008057104A1 (fr) Utilisation d'associations réversibles thermiques pour de meilleures interactions entre polymères
US20090227702A1 (en) High refractive index oxygen permeable contact lens system and method
WO2023031818A1 (fr) Procédé de production de lentilles de contact à base d'hydrogel de silicone mouillables
JP3855464B2 (ja) プラスチック成形品

Legal Events

Date Code Title Description
DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06844540

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06844540

Country of ref document: EP

Kind code of ref document: A1